Loading…

Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state

Background  In obese subjects, chronic low‐grade inflammation contributes to an increased risk of metabolic abnormalities, which are reversed by weight loss. Sustained weight loss, however, is difficult to achieve and more insight into dietary approaches on anti‐inflammatory responses in obese subje...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical investigation 2004-11, Vol.34 (11), p.766-773
Main Authors: Jellema, A., Plat, J., Mensink, R. P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background  In obese subjects, chronic low‐grade inflammation contributes to an increased risk of metabolic abnormalities, which are reversed by weight loss. Sustained weight loss, however, is difficult to achieve and more insight into dietary approaches on anti‐inflammatory responses in obese subjects is needed. In this respect, fish oil deserves attention. Material and methods  Eleven obese men (BMI: 30–35 kg m−2) received daily fish oil (1·35 g n‐3 fatty acids) or placebo capsules in random order for 6 weeks. Eight subjects continued with a weight reduction study that lasted 8 weeks. Mean weight loss was 9·4 kg. At the end of each experimental period a postprandial study was performed. Results  Relative to fasting concentrations, interleukin‐6 (IL‐6) levels increased by 75% 2 h and by 118% 4 h after the meal (P 
ISSN:0014-2972
1365-2362
DOI:10.1111/j.1365-2362.2004.01414.x